22.4 C
New York
Monday, June 30, 2025

Aurinia Pharmaceuticals to Hold Conference Call on June 30, 2025 to Review AUR200 Phase 1 Study Findings


Aurinia Pharmaceuticals to Host Conference Call to Discuss AUR200 Phase 1 Study Results on June 30, 2025

Related Articles

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe

Latest Articles